ML
XBI icon

McAdam LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

McAdam LLC’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
1,585
-29
-2% -$3.92K 0.01% 428
2026
Q1 		$206K Buy
+1,614
New +$201K 0.01% 406
2025
Q3 		– Sell
-3,273
Closed -$271K – 412
2025
Q2 		$271K Buy
3,273
+159
+5% +$12.7K 0.01% 307
2025
Q1 		$253K Sell
3,114
-3,288
-51% -$294K 0.02% 285
2024
Q4 		$577K Sell
6,402
-1,248
-16% -$121K 0.03% 182
2024
Q3 		$756K Sell
7,650
-413
-5% -$40.6K 0.04% 154
2024
Q2 		$748K Sell
8,063
-3,105
-28% -$278K 0.05% 145
2024
Q1 		$1.06M Buy
11,168
+2,956
+36% +$274K 0.07% 113
2023
Q4 		$733K Buy
8,212
+295
+4% +$21.9K 0.05% 130
2023
Q3 		$578K Sell
7,917
-252
-3% -$20.1K 0.05% 145
2023
Q2 		$680K Buy
8,169
+34
+0.4% +$2.84K 0.06% 133
2023
Q1 		$620K Sell
8,135
-1,385
-15% -$115K 0.06% 136
2022
Q4 		$1.07M Buy
9,520
+654
+7% +$52.9K 0.11% 74
2022
Q3 		$703K Sell
8,866
-274
-3% -$23.1K 0.08% 112
2022
Q2 		$679K Sell
9,140
-678
-7% -$50.9K 0.07% 116
2022
Q1 		$882K Buy
9,818
+298
+3% +$27.5K 0.08% 86
2021
Q4 		$1.07M Sell
9,520
-726
-7% -$87.6K 0.11% 74
2021
Q3 		$1.29M Sell
10,246
-1,876
-15% -$242K 0.14% 67
2021
Q2 		$1.52M Buy
12,122
+3,893
+47% +$512K 0.17% 63
2021
Q1 		$1.12M Buy
8,229
+4,220
+105% +$632K 0.16% 61
2020
Q4 		$594K Buy
+4,009
New +$513K 0.09% 77

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

McAdam LLC's XBI Position: Q2 2026 in Review

McAdam LLC reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.8% in Q2 2026, selling an estimated $3.92K and leaving 1,585 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #428.

McAdam LLC first reported a position in XBI in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.52M in Q2 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • McAdam LLC held 1,585 shares of State Street SPDR S&P Biotech ETF worth $251K as of Q2 2026.
  • McAdam LLC sold 29 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.92K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #428 holding.
  • McAdam LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 21 quarters since.
  • McAdam LLC's State Street SPDR S&P Biotech ETF position peaked at $1.52M in Q2 2021.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.